{"id":"azithromycin-and-amoxicillin","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Diarrhea"},{"rate":"3-10","effect":"Nausea"},{"rate":"2-8","effect":"Abdominal pain"},{"rate":"1-5","effect":"Rash"},{"rate":"1-5","effect":"Vomiting"},{"rate":"1-3","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azithromycin is a macrolide antibiotic that binds to the bacterial 50S ribosomal subunit and inhibits protein synthesis. Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Together, they provide broad-spectrum coverage against both gram-positive and gram-negative bacteria through complementary mechanisms.","oneSentence":"This is a combination of two antibiotics that work by inhibiting bacterial protein synthesis (azithromycin via 50S ribosomal subunit) and inhibiting bacterial cell wall synthesis (amoxicillin via beta-lactam mechanism).","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:28:04.945Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections susceptible to both azithromycin and amoxicillin"}]},"trialDetails":[{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT07296302","phase":"NA","title":"Antibiotic Prophylaxis Versus Placebo in Alveolar Bone Grafting: A Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Agnaldo Rocha de Souza Junior","startDate":"2026-02","conditions":"Alveolar Ridge Augmentation, Bone Grafting, Antibiotic Prophylaxis","enrollment":150},{"nctId":"NCT07183462","phase":"PHASE4","title":"Azithromycin and Ampicillin for Late PPROM","status":"RECRUITING","sponsor":"Sheba Medical Center","startDate":"2025-09-10","conditions":"Pregnancy Complications, Infectious, Premature Birth, Neonatal Diseases and Abnormalities","enrollment":311},{"nctId":"NCT02707042","phase":"PHASE1","title":"Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-03-22","conditions":"Normal Physiology, Healthy","enrollment":108},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":"Preterm Premature Rupture of Membranes (PPROM), Prophylaxis, Perinatal Outcomes","enrollment":40},{"nctId":"NCT03273296","phase":"PHASE4","title":"Effect of Antibiotics on Gut Microbiome and Plasma Metabolome","status":"COMPLETED","sponsor":"Finnish Institute for Health and Welfare","startDate":"2017-10-15","conditions":"Microbial Colonization","enrollment":39},{"nctId":"NCT03479736","phase":"","title":"A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-20","conditions":"Retinal Detachment, Achilles Tendon, Aneurysm, Dissecting","enrollment":117911},{"nctId":"NCT06461429","phase":"NA","title":"PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol]","status":"NOT_YET_RECRUITING","sponsor":"University of Melbourne","startDate":"2025-11-01","conditions":"Preterm Birth","enrollment":100000},{"nctId":"NCT05345457","phase":"PHASE4","title":"Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age","status":"RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2023-01-13","conditions":"Pregnancy Preterm, Pregnancy Prom, PROM, Preterm (Pregnancy)","enrollment":88},{"nctId":"NCT06917157","phase":"PHASE4","title":"Latency Antibiotics for Previable Rupture Of Membranes Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-05-01","conditions":"Preterm Prelabor Rupture of Membranes (PPROM)","enrollment":60},{"nctId":"NCT06906757","phase":"NA","title":"Preterm Rupture of Membranes Optimising Antibiotics Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Melbourne","startDate":"2025-09","conditions":"PPROM, Preterm","enrollment":3900},{"nctId":"NCT05473234","phase":"PHASE3","title":"Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2022-10-06","conditions":"Severe Acute Malnutrition","enrollment":310},{"nctId":"NCT05553743","phase":"","title":"Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2014-03-27","conditions":"Breastfeeding, COVID-19 Infection, COVID-19 Vaccine","enrollment":5000},{"nctId":"NCT06207786","phase":"NA","title":"Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2024-09-01","conditions":"Skin Cancer, Skin Cancer Face, Malignant Cutaneous Adnexal Neoplasm","enrollment":""},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04669717","phase":"PHASE4","title":"Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies","status":"RECRUITING","sponsor":"University of Geneva, Switzerland","startDate":"2021-09-01","conditions":"Periodontal Diseases, Antibiotics, Pharmacokinetics","enrollment":45},{"nctId":"NCT03237182","phase":"PHASE4","title":"The Individualized M(X) Drug-resistant TB Treatment Strategy Study","status":"TERMINATED","sponsor":"Centre for the AIDS Programme of Research in South Africa","startDate":"2017-06-14","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":205},{"nctId":"NCT03187834","phase":"PHASE4","title":"Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2017-07-04","conditions":"Child Development","enrollment":252},{"nctId":"NCT03568643","phase":"PHASE3","title":"Azithromycin for Uncomplicated Severe Acute Malnutrition in Burkina Faso (Pilot)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2020-06-03","conditions":"Uncomplicated Severe Acute Malnutrition","enrollment":301},{"nctId":"NCT03248297","phase":"PHASE4","title":"Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2018-01-12","conditions":"Postpartum Sepsis, Postpartum Endometritis, Postpartum Fever","enrollment":756},{"nctId":"NCT05293977","phase":"NA","title":"Short-Term Use of Antibiotics and Adherence Level","status":"COMPLETED","sponsor":"Jordan University of Science and Technology","startDate":"2020-08-03","conditions":"Acute Infection","enrollment":589},{"nctId":"NCT03545373","phase":"PHASE3","title":"Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2019-02-25","conditions":"Tuberculosis, Respiratory Tract Infections, Pneumonia","enrollment":1583},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT04696003","phase":"PHASE3","title":"Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion","status":"UNKNOWN","sponsor":"Martin-Luther-Universität Halle-Wittenberg","startDate":"2021-01-01","conditions":"Bronchopulmonary Dysplasia, Necrotizing Enterocolitis, Intracranial Hemorrhages","enrollment":68},{"nctId":"NCT04047849","phase":"PHASE4","title":"Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA","status":"RECRUITING","sponsor":"Woman's","startDate":"2019-08-28","conditions":"Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture), Rupture of Membranes; Premature, Rupture of Membranes; Premature, Affecting Fetus","enrollment":34},{"nctId":"NCT04363060","phase":"PHASE3","title":"Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit","status":"UNKNOWN","sponsor":"Nantes University Hospital","startDate":"2020-04-30","conditions":"COVID-19 Pneumonia","enrollment":104},{"nctId":"NCT02297815","phase":"","title":"Comparative Effectiveness of Antibiotics for Respiratory Infections","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2014-01","conditions":"Acute Otitis Media, Acute Sinusitis, Group A Streptococcal Pharyngitis","enrollment":2472},{"nctId":"NCT02605122","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia","status":"TERMINATED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2016-04","conditions":"Community-acquired Bacterial Pneumonia","enrollment":97},{"nctId":"NCT01712711","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-09","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":40},{"nctId":"NCT01654549","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-04","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":40},{"nctId":"NCT03571230","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2018-07-01","conditions":"Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing","enrollment":400},{"nctId":"NCT03113344","phase":"","title":"Population Pharmacokinetics of Anti-infective Drugs in Children With Infectious Diseases","status":"UNKNOWN","sponsor":"Beijing Children's Hospital","startDate":"2017-06-21","conditions":"Children; Infection","enrollment":800},{"nctId":"NCT01561703","phase":"NA","title":"Comparing Healthcare Utilization Between Adenotonsillectomy Patients With and Without Postoperative Antibiotic Use","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2012-03","conditions":"Snoring, Strep Throat","enrollment":58},{"nctId":"NCT02726269","phase":"PHASE3","title":"Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico.","status":"COMPLETED","sponsor":"Asofarma de México S.A de C.V.","startDate":"2012-06","conditions":"Helicobacter Pylori Gastritis","enrollment":230},{"nctId":"NCT01820026","phase":"PHASE4","title":"Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2012-12","conditions":"Cirrhosis","enrollment":96},{"nctId":"NCT00717561","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-02","conditions":"Pneumonia","enrollment":60},{"nctId":"NCT01876108","phase":"PHASE2","title":"The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-07","conditions":"Fatty Liver, Liver Dysfunction, Insulin Resistance","enrollment":100},{"nctId":"NCT01759628","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-04","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":100},{"nctId":"NCT00643149","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-05","conditions":"Tonsillitis","enrollment":693},{"nctId":"NCT00042718","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2001-11","conditions":"Bronchitis, Chronic Bronchitis","enrollment":659},{"nctId":"NCT00649831","phase":"PHASE3","title":"A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2002-10","conditions":"Bronchitis, Chronic","enrollment":250},{"nctId":"NCT00643539","phase":"PHASE4","title":"Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat","status":"COMPLETED","sponsor":"Pfizer","startDate":"2002-12","conditions":"Tonsillitis","enrollment":360}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["azithromycin, amoxicillin"],"phase":"marketed","status":"active","brandName":"Azithromycin and amoxicillin","genericName":"Azithromycin and amoxicillin","companyName":"University of Alabama at Birmingham","companyId":"university-of-alabama-at-birmingham","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin and amoxicillin are antibiotics used to treat various bacterial infections, including community-acquired bacterial pneumonia. They are also studied as potential treatments for other conditions such as skin cancer and non-alcoholic fatty liver disease, although the evidence for these uses is limited.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}